Giulia Bottai
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- Cancer Genomics and Diagnostics 6
- MicroRNA in disease regulation 5
- Oncology 12
- Cancer Immunotherapy and Biomarkers 7
- Cancer-related Molecular Pathways 2
- Cancer Cells and Metastasis 2
- HER2/EGFR in Cancer Research 2
- Co-authors
- Libero Santarpia (23 shared papers)Balázs Győrffy (9 shared papers)Gyöngyi Munkácsy (3 shared papers)András Szabó (1 shared paper)András Lánczky (1 shared paper)Ádám Nagy (2 shared papers)George A. Călin (5 shared papers)Laura Paladini (3 shared papers)
- Journals
- Expert Opinion on Biological Therapy (2 papers)Cancer Research (2 papers)Breast Cancer Research and Treatment (2 papers)The Oncologist (2 papers)Current Pharmaceutical Design (2 papers)
- Partner nations
- ItalyUnited StatesHungary
In The Last Decade
Giulia Bottai
27 papers receiving 1.8k citations
Giulia Bottai's Hit Papers
Peers
Comparison fields: 5 of 92
- Cancer Research 735
- Oncology 485
- Molecular Biology 1.0k
- Immunology 185
- Pulmonary and Respiratory Medicine 208
Countries citing papers authored by Giulia Bottai
This map shows the geographic impact of Giulia Bottai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Bottai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Bottai more than expected).
Fields of papers citing papers by Giulia Bottai
This network shows the impact of papers produced by Giulia Bottai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Bottai. The network helps show where Giulia Bottai may publish in the future.
Co-authors
The 25 scholars most cited alongside Giulia Bottai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients Hit paper breakdown → | 2016 | 587 |
| 2 | 2014 | 187 | |
| 3 | 2016 | 153 | |
| 4 | 2015 | 138 | |
| 5 | 2015 | 129 | |
| 6 | 2012 | 95 | |
| 7 | 2016 | 91 | |
| 8 | 2013 | 68 | |
| 9 | 2014 | 60 | |
| 10 | 2016 | 46 | |
| 11 | 2016 | 43 | |
| 12 | 2016 | 38 | |
| 13 | 2014 | 37 | |
| 14 | 2017 | 36 | |
| 15 | 2017 | 33 | |
| 16 | 2012 | 33 | |
| 17 | 2018 | 23 | |
| 18 | 2017 | 16 | |
| 19 | 2018 | 14 | |
| 20 | 2020 | 7 |
About Giulia Bottai
Giulia Bottai is a scholar working on Cancer Research, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Dermatology, having authored 27 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Cancer Genomics and Diagnostics (6 papers), MicroRNA in disease regulation (5 papers), Ferroptosis and cancer prognosis (3 papers), RNA Interference and Gene Delivery (2 papers), Cancer-related Molecular Pathways (2 papers), Cancer Cells and Metastasis (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Cancer Research (735 citations), Oncology (485 citations), Molecular Biology (1.0k citations), Immunology (185 citations) and Pulmonary and Respiratory Medicine (208 citations). Giulia Bottai has collaborated with scholars based in Italy, United States and Hungary. Frequent co-authors include Libero Santarpia, Balázs Győrffy, Gyöngyi Munkácsy, András Szabó, András Lánczky, Ádám Nagy, George A. Călin, Laura Paladini, Carlotta Raschioni and Bjørn Naume. Their work appears in journals such as Expert Opinion on Biological Therapy, Cancer Research, Breast Cancer Research and Treatment, The Oncologist and Current Pharmaceutical Design.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.